Sublethal CAP treatment enhances F. keratoplasticum amphotericin B sensitivity.

Colony forming unit enumeration of F. keratoplasticum conidia treated with amphotericin B, CAP alone, or a combination of amphotericin B and cold atmospheric plasma (CAP; 22 kV, 180 s) following 72 h incubation post-exposure. Significant differences relative to the no-drug control (0 µg/mL) within each treatment group (Amphotericin B and Amphotericin B + CAP) are indicated, as well as significant differences between treatment groups at each antifungal drug concentration; * p < 0.05, ** p < 0.01,***p < 0.001, **** p < 0.0001 (mean ± SEM; n = 6).